Clinical Trial Update: A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a latanoprost punctal plug delivery system for ocular hypertension or open-angle glaucoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: WITHDRAWN